Holdings

Symbol Grade Price % Change Allocation
LLY D 0.75 11.53
BSX A 0.42 6.31
ISRG A 0.38 4.82
ABBV A -0.07 4.70
AMGN D -0.18 4.34
PODD C -0.82 4.00
MRK F -2.32 3.89
DHR C -0.24 3.70
ABT B 0.07 3.54
MTD B 1.39 3.25
HUM F -11.79 3.03
BMRN F -0.63 2.66
ALGN D -2.97 1.93
IDXX D -1.91 1.72
ARGX A 0.50 1.71
ALNY C -1.63 1.62
VEEV C -0.05 1.61
NBIX F -0.18 1.54
TMDX D -0.83 0.78
RARE C -1.70 0.74
PCVX B -1.12 0.73
CGON C -1.36 0.67
NTRA A 3.08 0.64
WST D 0.00 0.63
GMAB F -1.90 0.59
MDGL F -0.09 0.46
CLDX F -6.76 0.46
BPMC F 0.84 0.46
XENE D 1.14 0.43
ANAB D 0.55 0.32
IRTC F -0.77 0.30

Recent News for Goldman Sachs Future Health Care Equity ETF & its Holdings

Date Stock Title
Oct 2 BSX Why Boston Scientific (BSX) Outpaced the Stock Market Today
Oct 2 ABT Abbott (ABT) Outperforms Broader Market: What You Need to Know
Oct 2 HUM Humana cut to underperform by BofA on margin recovery delay
Oct 2 LLY Jim Cramer Remains Steadfast On Eli Lilly and Company (NYSE:LLY)
Oct 2 HUM Stocks to Watch Wednesday: Tesla, Humana, Nike, Joby Aviation
Oct 2 XENE Xenon to Present at BofA Securities 2024 CNS Therapeutics Virtual Conference
Oct 2 HUM Humana stock falls as govt. changes Medicare ratings
Oct 2 NBIX The Play On Neurocrine Biosciences
Oct 2 HUM Stock Of The Day: Will Humana Remember?
Oct 2 LLY Eli Lilly to Invest $4.5 Billion to Open New Drug Manufacturing, Development Center
Oct 2 HUM Wall Street Lunch: Humana Shares Hit Hard
Oct 2 HUM Humana stock slides on lower ratings for its Medicare Advantage plans
Oct 2 HUM Humana Star Ratings plunge is latest in recent Medicare setbacks
Oct 2 HUM Heard on the Street: Humana Could Plunge Into Cigna’s Arms
Oct 2 HUM Humana Stock Plunges as Insurer's Medicare Plan Ratings Plummet
Oct 2 HUM Humana stock plunges as insurer falters on Medicare star ratings
Oct 2 LLY Drugmaker Lilly slates another $4.5B for manufacturing and drug development improvements
Oct 2 LLY Here's Why You Should Consider Buying Jazz Pharmaceuticals' Stock
Oct 2 LLY Eli Lilly Commits $4.5B To New Facility, Banking On Mounjaro, Zepbound's Weight Loss Success Despite Short-Term Stock Challenges
Oct 2 BSX SRDX Stock Down Despite FDA Clearance for Pounce XL System
Goldman Sachs Future Health Care Equity ETF is an exchange traded fund launched and managed by Goldman Sachs Asset Management, L.P. The fund invests in the public equity markets across the globe. It invests in stocks of companies operating across health care including genomics, precision medicine, technology-enabled procedures, and digital healthcare sectors. The fund invests in growth and value stocks of companies across diversified market capitalization. The fund employs fundamental analysis and quantitative with to create its portfolio. It seeks to benchmark the performance of its portfolio against the MSCI ACWI Health Care Index. The fund employs proprietary research to create its portfolio. Goldman Sachs Future Health Care Equity ETF was formed on November 9, 2021 and is domiciled in the United States.
Exchange Traded Funds SPDR Synthetic Replication Genomics Goldman Sachs
Back to the Main GDOC Page...